ALK and neuroblastoma: We add to this evidence by showing that shRNA-mediated NF1 knockdown renders two oncogenic ALK-driven human neuroblastoma cell lines resistant to pharmacological ALK inhibition, and by confirming that ALK mRNA is expressed in neurofibroma-derived NF1−/− human Schwann cells.